First published 17/08/2022
Back in the post-market crash, pre-vaccination world of Q3 2020, we published an article begging the question where are you investing your clients now?
In the article we promoted the Mariana 10:10 Plan August 2020, emphasising that its defined outcomes under defined circumstances, paired with its ten-year maximum investment term, should afford investors a certain peace of mind – not least given the context that the article was written in.
Each backed by Goldman Sachs and linked to the performance of the FTSE 100 Index, the Mariana 10:10 Plan August 2020 offered three investment Options with potential investment returns per year held of 7%, 8.75% and 10% respectively.
All three Options matured on their second anniversary (15 August 2022), with the FTSE 100 index having recovered significantly over the two years following our original promotion.
Data sourced from StructuredProductReview.com.
|
Plan Gain |
Annualised Return |
Option 1 |
14% |
6.77% |
Option 2 |
17.5% |
8.4% |
Option 3 |
20% |
9.54% |
One criticism of structured products is that they cap the growth potential so may result in lower returns than alternative, uncapped investments such as tracker funds in a sustained bull market. For example, the FTSE 100 Index rose by 23.3% over the term of the August 2020 Mariana 10:10 Plan (14th August 2020 – 15th August 2022) and so with the benefit of hindsight, investors would have achieved a greater return having been invested in a FTSE 100 tracker fund.
The benefit of hindsight allows for comparison and reflection, though it ignores behavioural finance and investor sentiment at the time of investment.
It is worth reminding yourself that at the time of our initial publication (8th July 2020), the FTSE 100 had fallen by 19.04% YTD and an established COVID-19 vaccination remained an unrealised global goal. Further national lockdowns were likely, markets were volatile and investor confidence was low. The 10:10 Plan offered a defined return for time in the market, the returns on offer were far from unattractive particularly given the circumstances and those returns were delivered.
Structured products offer investors a degree of capital protection against all but extremely adverse market conditions at the end of an investment term i.e. 10 years with the 10:10 Plan, and the opportunity to achieve significant capital gains in flat or even falling markets. The future position of the market in the short to medium term is mostly a matter of speculation.
Consider the situation back in 2018 when investor confidence was somewhat higher than it was at the peak of the pandemic. An investment into Option 1 of the March 2018 10:10 Plan could have similarly matured on its second anniversary, but conditions were such that it ran for four years, maturing earlier this year, realising a capital gain of 28.8% despite the FTSE 100 Index being down by 0.47% over the investment term.
These investments can play a significant role as part of a well-diversified portfolio alongside alternative investments such as, say, a FSTE 100 Tracker, and will provide a degree of peace of mind, predictability and protection in uncertain times.
Full details on the 10:10 Plan September 2022, including Lowes Summary Papers, can be found here.
FTSE 100 Data sourced from Investing.com
Structured investments put capital at risk.
Past performance is not a guide to the future.
Disclosure of interests: Lowes has provided input into the concept, development, promotion and distribution of the 10:10. Lowes has a commercial interest in these investments as a result of its involvement. Where Lowes is involved in advice on these investments to retail clients, it will not receive benefit of any fees for its involvement, other than those fees payable by the client to Lowes. Lowes has robust systems and controls in place to ensure that it manages any actual or potential conflicts of interests in its activities.
Also in this section
- How old is too old? Are structured products to die for?
- Product focus - October 2024
- Q3 2024 Issuance
- Q3 2024 maturity results
- A share of spread bets on steroids?
- Product focus - September 2024
- Maturities of the month - August 2024
- Right on time
- Product focus - August 2024
- Keep calm and zoom out
- 2,000 and counting
- Q2 2024 maturity results
- 20 years of autocall maturities
- Product focus - June 2024
- Fixed income or interest?
- Maturities of the month - May 2024
- The barrier debate - revisited
- Product focus - April 2024
- Maturities of the month - April 2024
- Time to call
- I don't believe markets are ever too high for Structured products!
- Notes on counterparty exposure
- Return of Nikkei
- Q1 2024 issuance
- Q1 2024 maturity results
- Structured Products – AAAAAGH!
- Hop in CIBC
- Re-enter Santander
- How to build a financial fortune - revisited
- Issuance in 2023
- Where's the risk?
- Questionable offerings
- Challenging the case against structured products - 'Loss of dividends'
- Navigating the investment landscape
- Challenging the case against structured products - Counterparty risk
- 6-year autocalls approaching final destination
- 1,750 FTSE capital at risk autocall maturities
- The leopard that changed her spots
- Q3 2023
- Challenging the case against structured products - Keydata
- Dilemmas for UK IFA's and the unique role of Structured Products
- 'High charges'
- Precipice bonds
- Intro
- FTSE 100 Contingent Income
- Indexing the indices
- Something different
- Investing through volatility
- 100 10:10s
- The best or worst?
- The 10%/25% 'Rule' that never was
- Structured products and the yield curve
- Fixed income: Capital at risk?
- Prospects for UK inflation - and fun with A.I!
- The Barrier Debate
- More Deposits for now
- Last of the Americans
- What if?
- Time heals all wounds, we hope...
- How to diversify portfolios using structured products?
- The Proof Is In The Pudding...
- Debunking Structured Misconceptions
- 1,500 FTSE Capital-at-Risk Autocall Maturities
- Q3 2022 Maturity Results
- What do we prefer?
- Deposits vs Capital ‘Protected’
- There’s time yet…
- Where did you invest your clients?
- A Six-Month Reflection
- Return of the Rev Con
- Happy 2nd Birthday FTSE CSDI
- Q2 2022 Maturity Results
- The best and worst yet still the best
- Critique my Suitability - Mariana 10:10 Plan June 2022 (Option 2)
- 10/10 for 55 10:10’s
- Q1 2022 Maturity Results
- 'How to build a financial fortune': a follow up
- Critique my Suitability - Mariana 10:10 Plan April 2022 (Option 2)
- 2021 Capital-at-Risk Autocall Maturity Review
- An unwelcome return...
- CSDI's First Birthday
- Bon Anniversaire
- Introducing the FTSE Custom 100 Synthetic 3.5% Fixed Dividend Index
- Q3 2021 Maturity Results
- Critique my Suitability - Mariana 10:10 Plan October 2021 (Option 2)
- Blurring the lines...
- Beware of false knowledge; it is more dangerous than ignorance
- Good news, bad news...
- Certainty is Certainly a Benefit
- Critique my Suitability - Mariana 10:10 Plan September 2021 (Option 2)
- A Twenty-Year Progression
- Q2 2021 Maturity Results
- Nine 8:8s Post Positive Returns in Falling Markets
- Critique my Suitability
- Q1 2021 Maturity Results
- Morgan Stanley’s Marvelous Maturity Medley
Current Products
We review the UK's retail structured investment sector, providing pertinent support for Professional Advisers and relevant research tools.
View all ⟶